Michael Gillett BSc (Sheffield), CIMA (Chartered Institute of Management Accountants)
Research Fellow
Address:
HEDS, ScHARR
University of Sheffield
Regent Court, 30 Regent Street
Sheffield S1 4DA
Tel: (+44) (0)114 222 0688
Fax: (+44) (0)114 272 4095
E-mail: m.gillett@sheffield.ac.uk
Room: 2004
Biography
I joined the Health Economics and Decision Science at the School of Health and Related Research (ScHARR) from a financial background. Having spent 9 years within the NHS at purchaser and provider level, I worked in an analytical and modelling capacity within industry for two years before joining SCHARR. My academic achievements include a BSc in Mathematics from the University of Sheffield.
I have a particular interest in modelling the effect of policies and treatments for the long-term management of Type 2 diabetes and its complications. Specific projects completed include the Cost Effectiveness of Screening for Type 2 Diabetes (NCCHTA), the Cost Effectiveness of Lifestyle Interventions for the prevention of Type 2 diabetes (NCCHTA), and economic assessment of a DPP-IV inhibitor. I have completed an evaluation of the cost effectiveness of the DESMOND intervention, and have recently been working on the NICE Public Health guidance on "Prevention of type 2 diabetes: preventing pre-diabetes among adults in high-risk groups" and a project looking at risk factors for hypoglycaemia. I have also been involved in the early stages of a project on NICE guidance for the prevention of progression from prediabetes to Type 2 diabetes
Other experience includes economic evaluation of drugs to treat acute coronary syndromes, and development of a model for Barnsley PCT aimed at predicting the benefit of public health measures to reduce hospital admissions resulting from cardiovascular and renal disease.
Research interests
- Effectiveness and Cost-effectiveness of interventions to prevent and manage type 2 diabetes.
- Economic modelling of cardiovascular diseases
Professional Activities
I have been a reviewer for several journals articles and grant applications. I was also one of 50 delegates invited to a Diabetes-UK "Frontiers In Diabetes" conference on Prevention of Type 2 Diabetes in 2008 and was invited to contribute towards a background paper on the prevention of Type 2 diabetes for the 2010 Royal College of Physicians of Edinburgh Consensus conference on diabetes.
Current Projects
- NICE Prevention of Type 2 diabetes: preventing pre-diabetes among adults in high-risk groups. Lead modeller.
- NICE Preventing the progression of pre-diabetes to type 2 diabetes in adults. Lead modeller.
- Novartis Modelling the cost effectiveness of vildagliptin for the treatment of Type 2 diabetes. Principal investigator
I am a co-applicant on several grant applications in the field of type 2 diabetes including research around education, screening and prevention.
Key publications
- Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ (In Press)
- Who can prevent diabetes? Current issues in the prevention of type 2 diabetes. Goyder E, Simmons R, Gillett M. J R Coll Physicians Edinb 2010; 40 (Suppl 17):5-11
- Screening for type 2 diabetes: literature review and economic modelling. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A. Health Technology Assessment 2007 May;11(17):1-144.
- Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care 2007;30(6):1638-46 (as a member of Mount Hood 4 Modeling Group)
- Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period - a pilot study. Whitfield MD, Gillett M, Holmes M, Ogden E. Public Health 2006 Dec;120(12):1140-8.
- Risk of death, myocardial infarction and patterns of care delivered in non-ST elevation ACS patients with intermediate elevations in cardiac troponin T: a UK District General Hospital experience. Ray K, Bolton J, Veitch A, Sheridan P, Gillett M, Al Rifai A, ManivArmane R, Brennan A, Payne G, Baig W. British Journal of Cardiology 2004;12(2).